Integrated Network Analysis and Logistic Regression Modeling Identify Stage-specific Genes in Oral Squamous Cell Carcinoma

Overview

Journal BMC Med Genomics

Publisher Biomed Central

Specialty Genetics

Date 2015 Jul 17

PMID 26179909

Citations 8

Authors

Vinay Randhawa

Vishal Acharya

Affiliations

Soon will be listed here.

Abstract

Background: Oral squamous cell carcinoma (OSCC) is associated with substantial mortality and morbidity but, OSCC can be difficult to detect at its earliest stage due to its molecular complexity and clinical behavior. Therefore, identification of key gene signatures at an early stage will be highly helpful.

Methods: The aim of this study was to identify key genes associated with progression of OSCC stages. Gene expression profiles were classified into cancer stage-related modules, i.e., groups of genes that are significantly related to a clinical stage. For prioritizing the candidate genes, analysis was further restricted to genes with high connectivity and a significant association with a stage. To assess predictive power of these genes, a classification model was also developed and tested by 5-fold cross validation and on an independent dataset.

Results: The identified genes were enriched for significant processes and functional pathways, and various genes were found to be directly implicated in OSCC. Forward and stepwise, multivariate logistic regression analyses identified 13 key genes whose expression discriminated early- and late-stage OSCC with predictive accuracy (area under curve; AUC) of ~0.81 in a 5-fold cross-validation strategy.

Conclusions: The proposed network-driven integrative analytical approach can identify multiple genes significantly related to an OSCC stage; the classification model that is developed with these genes may help to distinguish cancer stages. The proposed genes and model hold promise for monitoring of OSCC stage progression, and our findings may facilitate cancer detection at an earlier stage, resulting in improved treatment outcomes.

Citing Articles

Identification of Novel Biomarkers for Ischemic Stroke Through Integrated Bioinformatics Analysis and Machine Learning.

Jia J, Niu L, Feng P, Liu S, Han H, Zhang B J Mol Neurosci. 2025; 75(1):13.

PMID: 39862324 DOI: 10.1007/s12031-025-02309-8.

Machine learning-driven discovery of novel therapeutic targets in diabetic foot ulcers.

Yu X, Wu Z, Zhang N Mol Med. 2024; 30(1):215.

PMID: 39543487 PMC: 11562697. DOI: 10.1186/s10020-024-00955-z.

Elucidating common biomarkers and pathways of osteoporosis and aortic valve calcification: insights into new therapeutic targets.

Lan Y, Peng Q, Shen J, Liu H Sci Rep. 2024; 14(1):27827.

PMID: 39537712 PMC: 11560947. DOI: 10.1038/s41598-024-78707-6.

Binary Response Analysis Using Logistic Regression in Dentistry.

Srimaneekarn N, Hayter A, Liu W, Tantipoj C Int J Dent. 2022; 2022:5358602.

PMID: 35310463 PMC: 8924599. DOI: 10.1155/2022/5358602.

Integrated multiplex network based approach for hub gene identification in oral cancer.

Mahapatra S, Bhuyan R, Das J, Swarnkar T Heliyon. 2021; 7(7):e07418.

PMID: 34258466 PMC: 8258848. DOI: 10.1016/j.heliyon.2021.e07418.

References

Xiao F, Bai Y, Chen Z, Li Y, Luo L, Huang J . Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. Eur J Cancer. 2014; 50(8):1541-54. DOI: 10.1016/j.ejca.2014.01.024. View

Snell K . Enzymes of serine metabolism in normal, developing and neoplastic rat tissues. Adv Enzyme Regul. 1984; 22:325-400. DOI: 10.1016/0065-2571(84)90021-9. View

Pawitan Y, Bjohle J, Amler L, Borg A, Egyhazi S, Hall P . Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 2005; 7(6):R953-64. PMC: 1410752. DOI: 10.1186/bcr1325. View

Pyeon D, Newton M, Lambert P, den Boon J, Sengupta S, Marsit C . Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 2007; 67(10):4605-19. PMC: 2858285. DOI: 10.1158/0008-5472.CAN-06-3619. View

Jiang Q, Yu Y, Ding X, Luo Y, Ruan H . Bioinformatics analysis reveals significant genes and pathways to target for oral squamous cell carcinoma. Asian Pac J Cancer Prev. 2014; 15(5):2273-8. DOI: 10.7314/apjcp.2014.15.5.2273. View

Dalman M, Deeter A, Nimishakavi G, Duan Z . Fold change and p-value cutoffs significantly alter microarray interpretations. BMC Bioinformatics. 2012; 13 Suppl 2:S11. PMC: 3305783. DOI: 10.1186/1471-2105-13-S2-S11. View

Sales G, Calura E, Cavalieri D, Romualdi C . graphite - a Bioconductor package to convert pathway topology to gene network. BMC Bioinformatics. 2012; 13:20. PMC: 3296647. DOI: 10.1186/1471-2105-13-20. View

Zhang J, Xiang Y, Ding L, Keen-Circle K, Borlawsky T, Ozer H . Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia. BMC Bioinformatics. 2010; 11 Suppl 9:S5. PMC: 2967746. DOI: 10.1186/1471-2105-11-S9-S5. View

Wong D, Todd R, Tsuji T, Donoff R . Molecular biology of human oral cancer. Crit Rev Oral Biol Med. 1996; 7(4):319-28. DOI: 10.1177/10454411960070040201. View

10.

Schulze A, Harris A . How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature. 2012; 491(7424):364-73. DOI: 10.1038/nature11706. View

11.

Liu K, Liu Z, Hao J, Chen L, Zhao X . Identifying dysregulated pathways in cancers from pathway interaction networks. BMC Bioinformatics. 2012; 13:126. PMC: 3443452. DOI: 10.1186/1471-2105-13-126. View

12.

Kommadath A, Bao H, Arantes A, Plastow G, Tuggle C, Bearson S . Gene co-expression network analysis identifies porcine genes associated with variation in Salmonella shedding. BMC Genomics. 2014; 15:452. PMC: 4070558. DOI: 10.1186/1471-2164-15-452. View

13.

Zhang Z, Wang J, Shen B, Peng C, Zheng M . The ABCC4 gene is a promising target for pancreatic cancer therapy. Gene. 2011; 491(2):194-9. DOI: 10.1016/j.gene.2011.09.029. View

14.

Takanashi M, Oikawa K, Fujita K, Kudo M, Kinoshita M, Kuroda M . Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers. Am J Pathol. 2008; 174(1):309-16. PMC: 2631343. DOI: 10.2353/ajpath.2009.080148. View

15.

Yamashita T, Forgues M, Wang W, Kim J, Ye Q, Jia H . EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res. 2008; 68(5):1451-61. DOI: 10.1158/0008-5472.CAN-07-6013. View

16.

Jones R, Thompson C . Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009; 23(5):537-48. PMC: 2763495. DOI: 10.1101/gad.1756509. View

17.

Reis P, Waldron L, Perez-Ordonez B, Pintilie M, Galloni N, Xuan Y . A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence. BMC Cancer. 2011; 11:437. PMC: 3198722. DOI: 10.1186/1471-2407-11-437. View

18.

ODonnell R, Kupferman M, Wei S, Singhal S, Weber R, OMalley B . Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene. 2004; 24(7):1244-51. DOI: 10.1038/sj.onc.1208285. View

19.

Toruner G, Ulger C, Alkan M, Galante A, Rinaggio J, Wilk R . Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet. 2004; 154(1):27-35. DOI: 10.1016/j.cancergencyto.2004.01.026. View

20.

Huggins C, Domenighetti A, Ritchie M, Khalil N, Favaloro J, Proietto J . Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate intervention. J Mol Cell Cardiol. 2008; 44(2):270-80. DOI: 10.1016/j.yjmcc.2007.11.020. View